Home | Contact Us | Site Map
Super Investor Insight
SUBSCRIBER LOGIN: Forgot Password?
From the Editors of Value Investor Insight
VII Home
SII Sample Issue
Subscribe To SII
SII Issue Archive
SuperInvestor Insight
4 Ways to Subscribe:
As low as $149 per year!
Print Out Subscription Form »
Print Out Subscription Form »
Subscribe now by calling:
866-988-9060 (toll-free)

Welcome to SuperInvestor Insight

The best investors regularly cite their "grapevine" in the investing business as a key source of great ideas. Not to mimic what others are doing, of course – they think for themselves – but to identify opportunities worthy of a closer look. As Bruce Berkowitz, manager of the highly successful Fairholme Fund, says: "Why wouldn't you look at what other great investors have found?"
SuperInvestor Insight is for investors looking to expand their own first-class investing grapevine. Based on the quarterly SEC filings of an elite cadre of value-oriented investment managers, SuperInvestor Insight draws both general and specific insight from what the best investors own, what they're buying and what they're selling.
Each quarterly issue of SuperInvestor Insight is filled with valuable information and analysis to inform profitable investment decisions. Here are highlights from the current issue:
Issue Highlights: September 7, 2016
What They're Buying
Deal-making once again attracted SuperInvestors' interest last quarter, particularly in the cable-TV and pharmaceutical industries.
Table: Booster Shots
Table: Biggest New Bets
What They're Selling
Selling conviction by star investors wasn’t collectively strong last quarter and appears mostly valuation based. Then there's Pfizer.
Table: Diminished Expectations
Table: Selling Out
What They Own
The list of widely held SuperInvestor stocks is top-heavy by industry, but it gets far more varied where there's a bit less consensus.
Table: Comfort Zone
Table: Doubling Down
Stock Spotlight
What beneath-the-surface events have to transpire for smart-money buyers of second-quarter IPO US Foods to be proven prescient.
Companies in this Issue
A – E
21st Century Fox, Agnico Eagle Mines, Allergan, Alliance Data Systems, Alphabet, American Tower, Amgen, Antero Resources, Anthem, Apple, B/E Aerospace, Biogen, Calpine, Carnival, Charter Communications, Cigna, Citigroup, Coca-Cola European Partners, Constellation Brands, Delta Air Lines, DepoMed
F – J
Facebook, FleetCor Technologies, Hilton, IMS Health, Infoblox, Intercontinental Exchange, JD.com
K – O
Lam Research, Legg Mason, Liberty Broadband, Liberty Global, Liberty Interactive Ventures, Liberty LiLAC, Lions Gate Entertainment, Macy’s, Marvell Technology, McDonald's, McKesson, Microsoft, Middleby, Molson Coors, Monsanto, Morgan Stanley, Motorola Solutions
P – T
PayPal, Pfizer, Philip Morris International, Priceline, Range Resources, Sensata Technologies, Shire, Signet Jewelers, Synergy Pharmaceuticals, Tesla Motors, Teva Pharmaceutical, Transdigm
U – Z
US Foods, Walgreens Boots, Yum Brands, Zayo Group
See for yourself how valuable SuperInvestor Insight can be. If you're not happy with your subscription for any reason, just cancel and receive a refund for the remaining issues in your subscription term.
Subscribe Now!
Discover the Value...
Read a Sample Issue
Sample Issue
Read a Sample Issue
The SuperInvestors
SuperInvestor Insight tracks today's best investors, including:
» John Paulson
» David Einhorn
» Lee Cooperman
» Seth Klarman
» John Griffin
» Glenn Greenberg
» Larry Robbins
... and many more
Learn More »

© 2016 Value Investor Media, Inc. All rights reserved.
Privacy Statement / Terms of Use
Contact Us